Colombia Fully Licenses Khiron and PharmaCielo Cannabis Operations

Two privately-held cannabis companies based in Canada, Khiron Life Sciences and PharmaCielo, are now fully licensed by Colombia to produce low and high THC medical cannabis. Khiron disclosed the news in a press release on Monday, suggesting that it will begin cultivation on 17 acres.

Khiron has now received all three requisite licences in Colombia, and we are positioned to continue the expansion of our business plan throughout Latin America. I would again like to thank the government of Colombia for their confidence in our team.

Alvaro Torres, President and CEO of Khiron

PharmaCielo boasted of becoming the world’s largest licensed producer in a press release issued today. The company is growing in open air greenhouses on 30 acres in Rionegro.

To say that we are excited is an understatement, as to date the Colombian government has issued licences only for the cultivation of non-psychoactive cannabis containing little to no THC.

Federico Cock-Correa, Director and CEO of PharmaCielo Colombia Holdings

Receipt of the dual licences for psychoactive and non-psychoactive cannabis containing THC and CBD, combined with the fact that we have Colombia’s only fully functional cultivation and processing facility inspected and approved by the government, allows PharmaCielo the opportunity to become Colombia’s first and leading producer of medicinal-grade oil extracts.

Colombia legalized medicinal cannabis in 2016. Both companies intend to export medical cannabis to other markets.

Published by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter